Atlas Trials

Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19.

Clinical trial NCT05305508 · COMPLETED

Trial details

NCT number
NCT05305508
Sponsor
Hervé SPECHBACH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19 Virus Disease
Start date
2022-05-17
Primary completion
2023-11-10
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.